Concepedia

Andrew Scribner

AS

8

Publications

339

Citations

8

H-Index

1997

Active since

Affiliations

Scynexis (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Andrew Scribner is an author at Scynexis (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1997–2013

8

Publications

8

Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents

Tesfaye Biftu, Dennis Feng, Michael H. Fisher et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 97 citations · Full text

, , +8

Synthesis and biological activity of imidazopyridine anticoccidial agents: Part I

Andrew Scribner, Richard Dennis, Jean S. Hong et al. · European Journal of Medicinal Chemistry · 2007 · 52 citations · Full text

, , +9

Synthesis and biological activity of anticoccidial agents: 5,6-Diarylimidazo[2,1-b][1,3]thiazoles

Andrew Scribner, Susan Meitz, Michael H. Fisher et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 49 citations

, , +3

Synthesis and biological activity of imidazopyridine anticoccidial agents: Part II

Andrew Scribner, Richard Dennis, Shuliang Lee et al. · European Journal of Medicinal Chemistry · 2007 · 37 citations

, , +9

Cyclophilin inhibitors as antiviral agents

Michael Peel, Andrew Scribner · Bioorganic & Medicinal Chemistry Letters · 2013 · 32 citations · Full text

, , +7

Rows per page

1–5 of 8